Honasa buys 58% of Fluence Pharma, opens nutraceuticals front beyond Mamaearth
Mamaearth parent Honasa Consumer is acquiring a 58% stake in Fluence Pharma, pushing the D2C beauty house into nutraceuticals. The move signals a category-stretch playbook as core personal care growth moderates, with Honasa betting adjacent wellness SKUs can ride the same digital-first distribution.
What happened
Honasa Consumer (Mamaearth parent) acquires 58% in Fluence Pharma, entering nutraceuticals. Bajaj Auto trades ex-buyback. Imagicaa Water Park reopens June 26 in
Key facts
- 58% stake in Fluence Pharma
- Rashi Peripherals 67% stake for Rs 368.5 cr
- Imagicaa revenue loss Rs 50 lakh
- Bajaj Auto ex-buyback
Why this matters
A 58% majority stake (not 100%) suggests Honasa wants Fluence's pharma DNA preserved while retaining control — a template worth studying for adjacency plays in regulated wellness categories.